1. Home
  2. STVN vs THG Comparison

STVN vs THG Comparison

Compare STVN & THG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • THG
  • Stock Information
  • Founded
  • STVN 1949
  • THG 1852
  • Country
  • STVN Italy
  • THG United States
  • Employees
  • STVN N/A
  • THG N/A
  • Industry
  • STVN Containers/Packaging
  • THG Property-Casualty Insurers
  • Sector
  • STVN Consumer Discretionary
  • THG Finance
  • Exchange
  • STVN Nasdaq
  • THG Nasdaq
  • Market Cap
  • STVN 6.2B
  • THG 5.6B
  • IPO Year
  • STVN 2021
  • THG 1995
  • Fundamental
  • Price
  • STVN $19.02
  • THG $163.52
  • Analyst Decision
  • STVN Buy
  • THG Buy
  • Analyst Count
  • STVN 3
  • THG 5
  • Target Price
  • STVN $29.33
  • THG $173.40
  • AVG Volume (30 Days)
  • STVN 633.0K
  • THG 186.8K
  • Earning Date
  • STVN 11-05-2024
  • THG 10-30-2024
  • Dividend Yield
  • STVN 0.31%
  • THG 2.08%
  • EPS Growth
  • STVN N/A
  • THG N/A
  • EPS
  • STVN 0.48
  • THG 10.00
  • Revenue
  • STVN $1,220,254,294.00
  • THG $6,181,900,000.00
  • Revenue This Year
  • STVN $3.01
  • THG N/A
  • Revenue Next Year
  • STVN $7.78
  • THG $4.66
  • P/E Ratio
  • STVN $39.99
  • THG $16.38
  • Revenue Growth
  • STVN 3.53
  • THG 4.01
  • 52 Week Low
  • STVN $16.56
  • THG $117.56
  • 52 Week High
  • STVN $34.73
  • THG $164.67
  • Technical
  • Relative Strength Index (RSI)
  • STVN 43.43
  • THG 69.03
  • Support Level
  • STVN $17.12
  • THG $160.32
  • Resistance Level
  • STVN $22.07
  • THG $164.67
  • Average True Range (ATR)
  • STVN 1.37
  • THG 3.54
  • MACD
  • STVN -0.05
  • THG 1.13
  • Stochastic Oscillator
  • STVN 21.48
  • THG 93.74

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through three operating segments: Commercial Lines, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

Share on Social Networks: